Global Genitourinary Partnering Deals, Trends, Players and Financials Analysis 2010-2016
Global Genitourinary Partnering 2010 to 2016 provides the full collection of Genitourinary disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Genitourinary disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Genitourinary deals.
The report presents financial deal terms values for Genitourinary deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Genitourinary Partnering 2010 to 2016 includes:
In Global Genitourinary Partnering 2010 to 2016, available deals and contracts are listed by:
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Genitourinary dealmaking
Chapter 3 - Financial deal terms for Genitourinary partnering
Chapter 4 - Leading Genitourinary deals and dealmakers
Chapter 5 - Genitourinary contract document directory
Chapter 6 - Genitourinary dealmaking by therapeutic target
For more information visit http://www.researchandmarkets.com/research/d85rjp/global
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
